Duane DeMong
29Patents
2h-index
107Co-inventors
56Inventor score
Filing activity: Jun 25, 2008 → Mar 31, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9718818B2 | Compounds inhibiting leucine-rich repeat kinase enzyme activity | Chemistry; Metallurgy | 21 | Active |
| US8361959B2 | Spiro-imidazolone derivatives as glucagon receptor antagonists | Chemistry; Metallurgy | 2 | Active |
| US10100042B2 | [5,6]—fused bicyclic antidiabetic compounds | Chemistry; Metallurgy | 2 | Active |
| US9840512B2 | Antidiabetic bicyclic compounds | Chemistry; Metallurgy | 1 | Active |
| US8735604B2 | Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use | Chemistry; Metallurgy | 1 | Active |
| US9416126B2 | Compounds inhibiting leucine-rich repeat kinase enzyme activity | Chemistry; Metallurgy | 1 | Active |
| US8623873B2 | Substituted piperazines as CB1 antagonists | Chemistry; Metallurgy | 1 | Active |
| US10793557B2 | Sting agonist compounds | Chemistry; Metallurgy | 1 | Active |
| US8623818B2 | Glucagon receptor antagonists, compositions, and methods for their use | Chemistry; Metallurgy | 1 | Active |
| US11312719B2 | 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use | Emerging Cross-Sectional Technologies | 1 | Active |
| US10968193B2 | Antidiabetic bicyclic compounds | Chemistry; Metallurgy | 1 | Active |
| US11702430B2 | Aza-benzothiophene compounds as STING agonists | Chemistry; Metallurgy | 0 | Active |
| US10335399B2 | Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2—negative allosteric modulators, compositions, and their use | Human Necessities | 0 | Active |
| US10806724B2 | Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their use | Human Necessities | 0 | Active |
| US9809568B2 | Compounds inhibiting leucine-rich repeat kinase enzyme activity | Chemistry; Metallurgy | 0 | Active |
| US9006228B2 | Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment | Chemistry; Metallurgy | 0 | Active |
| US9440952B2 | Compounds inhibiting leucine-rich repeat kinase enzyme activity | Chemistry; Metallurgy | 0 | Active |
| US12060357B2 | 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use | Emerging Cross-Sectional Technologies | 0 | Active |
| US9493440B2 | Compounds inhibiting leucine-rich repeat kinase enzyme activity | Chemistry; Metallurgy | 0 | Active |
| US12263171B2 | 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use | Chemistry; Metallurgy | 0 | Active |
| US10662171B2 | Antidiabetic bicyclic compounds | Chemistry; Metallurgy | 0 | Active |
| US8957062B2 | Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment | Chemistry; Metallurgy | 0 | Active |
| US10131651B2 | [7,6]-fused bicyclic antidiabetic compounds | Chemistry; Metallurgy | 0 | Active |
| US12414952B2 | Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use | Chemistry; Metallurgy | 0 | Active |
| US11225471B2 | Antidiabetic bicyclic compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.